Last reviewed · How we verify
NCT05046756
Postoperative Prognosis Management Service Based mHealth for Colon Cancer Patients
NA trial testing mHealth App and wearable device in Colon Cancer in 324 participants. Status unknown.
30 May 2023
Quick facts
| Lead sponsor | Korea University Anam Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 324 |
| Start date | 11 May 2021 |
| Primary completion | 30 May 2023 |
| Estimated completion | 30 May 2024 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- mHealth App and wearable device
Conditions studied
- Colon Cancer — all drugs for Colon Cancer →
Sponsor
Korea University Anam Hospital
Who can join
Adults 19 to 75, any sex, with Colon Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Recently, the use of mobile health is increasing for the purpose of managing prognosis such as recurrence, survival and quality of life by using a wearable smart band and a smartphone application. In the era of the 4th revolution, mobile health for the purpose of comprehensive prognosis for cancer patients is becoming a very good tool. It is possible to confirm the clinical significance of short-term and temporary health care through a mobile application and a smart band during the treatment process for cancer patients, but the study is insufficient to generalize the number of subjects. Therefore, for colon cancer patients who need prognosis management after surgery, we will investigate the effect of a mobile application using a smart band which has a modular structure reflecting the treatment method and treatment process after surgery. This study targets patients who underwent prostate cancer surgery. An intervention group (App+IoT device) uses a smart care application for 12 months. This application was tailored for prostate cancer patients and created by reflecting the treatment process after surgery. And they also uses a wearable smart band for 12 months. Control group is provided general education through the hospital brochure. Evaluation will be conducted 2-3days after surgery (before discharge), and at 1, 3, 6, and 12 months after surgery.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Application of wearables for remote monitoring of oncology patients: A scoping review.
Cloß K, Verket M, Müller-Wieland D, Marx N, et al · · 2024 · cited 16× · PMID 38481796 · DOI 10.1177/20552076241233998 -
Effectiveness of personalized treatment stage-adjusted digital therapeutics in colorectal cancer: a randomized controlled trial.
Kim I, Lim JY, Kim SW, Shin DW, et al · · 2023 · cited 3× · PMID 37013485 · DOI 10.1186/s12885-023-10728-2
Verify or expand the search:
- PubMed search for NCT05046756
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of mHealth App and wearable device
Trials testing the same drug.
- NCT05021952 — Postoperative Prognosis Management Service Based mHealth for Prostate Cancer Patients · NA · unknown
- NCT04907591 — Postoperative Prognosis Management Service Based mHealth for Gastric Cancer Patients · NA · unknown
Other recruiting trials for Colon Cancer
Currently open trials in the same condition.
- NCT06923787 — Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patient · Phase 2 · recruiting
- NCT07279077 — Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advance · Phase 2 · recruiting
- NCT07205965 — The Effect of Acceptance and Commitment Approach-Based Psychoeducation in Cancer Survivors · NA · active not recruiting
- NCT07285356 — Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy · NA · recruiting
- NCT07161713 — SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors · NA · recruiting
Other Korea University Anam Hospital trials
Trials by the same sponsor.
- NCT07510932 — Fruquintinib In Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies in South Korea Patients · Phase 2 · not yet recruiting
- NCT07280780 — CGM-Based Glycemic Analysis After ESI · not yet recruiting
- NCT07189000 — Patient-centered REhabilitation Program to Advance REcovery · NA · not yet recruiting
- NCT07246148 — NOn-inVAsive Blood Pressure Monitoring in Intracranial Aneurysm Embolization · NA · recruiting
- NCT07376980 — The SMART Trial: Modified Single-Stapled Anastomosis in Laparoscopic or Robotic Low Anterior Resection for Rectal Cancer · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05046756 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Korea University Anam Hospital
- Last refreshed: 16 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05046756.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing